How GLP-1s are transforming binge eating and big food
An unexpected consequence of these blockbuster drugs
An unexpected consequence of these blockbuster drugs
State of the union, and where we go from here
Lessons learned after a strategy shift featuring Brightline CEO Naomi Allen and investor Alyssa Jaffee
I’m introducing a new series to ask experts in the space tough questions about topics of the moment
One longtime women's health investor weighs in...
Important new data is out today indicating that might be the case — and for the very reason you might expect!
Our guide to the new regulation, plus the biggest opportunities and the challenges
Build for the needs of a community, not a single condition
Not all companies (or hormones) are created equal